J&J Stakes Claim For Growing Obesity And Diabetes Markets
This article was originally published in The Gray Sheet
Executive Summary
The growing global incidence of obesity and diabetes is attracting attention from Johnson & Johnson, which says it will target the markets more aggressively with comprehensive strategies that gather resources from across the company's devices, pharmaceutical and consumer products businesses